General Atlantic
Latest statistics and disclosures from General Atlantic's latest quarterly 13F-HR filing:
- Top 5 stock holdings are DLO, XP, ALKT, HRT, SQSP, and represent 69.79% of General Atlantic's stock portfolio.
- Added to shares of these 4 stocks: AKRO (+$87M), PHVS (+$72M), IMCR (+$36M), WISH.
- Reduced shares in these 9 stocks: Engagesmart (-$1.6B), SQSP (-$219M), Karuna Therapeutics Ord (-$167M), MBLY (-$115M), DUOL (-$96M), YOU (-$76M), FUTU (-$64M), Arco Platform Cl A Ord (-$57M), BZFD.
- Sold out of its positions in BZFD, YOU, DUOL, Engagesmart, FUTU, Karuna Therapeutics Ord, Arco Platform Cl A Ord.
- General Atlantic was a net seller of stock by $-2.2B.
- General Atlantic has $4.3B in assets under management (AUM), dropping by -33.55%.
- Central Index Key (CIK): 0001017645
Tip: Access up to 7 years of quarterly data
Positions held by General Atlantic consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for General Atlantic
General Atlantic holds 22 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Dlocal Cl A (DLO) | 21.8 | $939M | 64M | 14.70 |
|
|
| XP Cl A (XP) | 17.7 | $760M | 30M | 25.66 |
|
|
| Alkami Technology (ALKT) | 10.7 | $460M | 19M | 24.57 |
|
|
| Hireright Holdings Corporati (HRT) | 10.6 | $458M | 32M | 14.27 |
|
|
| Squarespace Cl A (SQSP) | 9.0 | $387M | -36% | 11M | 36.44 |
|
| Alignment Healthcare (ALHC) | 7.0 | $303M | 61M | 4.96 |
|
|
| Pharvaris N V (PHVS) | 4.0 | $174M | +70% | 7.5M | 23.11 |
|
| European Wax Center Cl A (EWCZ) | 4.0 | $170M | 13M | 12.98 |
|
|
| Akero Therapeutics (AKRO) | 3.1 | $132M | +193% | 5.2M | 25.26 |
|
| Centessa Pharmaceuticals Adr (CNTA) | 2.5 | $109M | 9.7M | 11.30 |
|
|
| Immunocore Ads (IMCR) | 2.3 | $98M | +58% | 1.5M | 65.00 |
|
| Hutchmed Ads (HCM) | 1.6 | $67M | 4.0M | 16.80 |
|
|
| Blend Labs Cl A (BLND) | 1.4 | $62M | 19M | 3.25 |
|
|
| Royalty Pharma Shs Class A (RPRX) | 1.1 | $46M | 1.5M | 30.37 |
|
|
| Mobileye Cl A (MBLY) | 0.9 | $38M | -74% | 1.2M | 32.15 |
|
| Riskified Cl A (RSKD) | 0.7 | $29M | 5.3M | 5.41 |
|
|
| Third Harmonic Bio (THRD) | 0.6 | $28M | 3.0M | 9.44 |
|
|
| Acelyrin Ord (SLRN) | 0.5 | $20M | 2.9M | 6.75 |
|
|
| Opendoor Technologies (OPEN) | 0.4 | $19M | 6.3M | 3.03 |
|
|
| Wish Cl A (WISH) | 0.1 | $3.5M | 610k | 5.69 |
|
|
| Grove Collaborative Cl A (GROV) | 0.0 | $1.6M | 936k | 1.67 |
|
|
| Adagene Adr (ADAG) | 0.0 | $739k | 264k | 2.80 |
|
Past Filings by General Atlantic
SEC 13F filings are viewable for General Atlantic going back to 2010
- General Atlantic 2024 Q1 filed May 15, 2024
- General Atlantic 2023 Q3 filed Nov. 14, 2023
- General Atlantic 2023 Q2 filed Aug. 11, 2023
- General Atlantic 2023 Q1 filed May 15, 2023
- General Atlantic 2022 Q4 filed Feb. 14, 2023
- General Atlantic 2022 Q3 filed Nov. 14, 2022
- General Atlantic 2022 Q2 filed Aug. 12, 2022
- General Atlantic 2022 Q1 filed May 16, 2022
- General Atlantic 2021 Q4 filed Feb. 11, 2022
- General Atlantic 2021 Q3 filed Nov. 15, 2021
- General Atlantic 2021 Q2 filed Aug. 13, 2021
- General Atlantic 2021 Q1 filed May 17, 2021
- General Atlantic 2020 Q4 filed Feb. 12, 2021
- General Atlantic 2020 Q3 filed Nov. 13, 2020
- General Atlantic 2020 Q2 filed Aug. 13, 2020
- General Atlantic 2020 Q1 filed May 14, 2020